CANCER CONTROL 润色咨询

Cancer Control

出版年份:暂无数据 年文章数:57 投稿命中率:25.0%

出版周期:Quarterly 自引率:0.4% 审稿周期:平均8.5月

前往期刊查询

投稿信息

投稿信息
审稿速度
平均8.5月 (网友贡献,非官方数据)
投稿命中率
25.0% (网友贡献,非官方数据)
审稿费用
暂无数据
版面费用
暂无数据
中国人发表比例
2019年中国人文章占该期刊总数量19.30% (2018年为22.50%)
自引率
0.4 %
年文章数
57
期刊官网
点击查看 (点击次数:5827)
点击查看 (点击次数:3460次)
作者需知
点击查看 (点击次数:163次)
期刊简介
稿件收录要求

Cancer Control is a JCR-ranked open access journal whose mission is to advance the prevention, detection, diagnosis, treatment, and palliative care of cancer by enabling researchers, doctors, policymakers, and other healthcare professionals to freely share research along the cancer control continuum. Our vision is a world where gold-standard cancer care is the norm, not the exception.
The journal is organized into five topical sections, as well as a sixth curated by members of the Moffitt Cancer Center. The topical sections are inspired by the foci of the cancer control continuum (prevention, detection, diagnosis, treatment, survivorship).

Article Types and Topics of Interest
Cancer Control welcomes original research (clinical studies), reviews, and commentaries. We encourage submissions relating to advances in the following areas:

  • Communications in cancer research
  • Surveillance
  • Social Determinants of Health Disparities
  • Genetic Testing
  • Decision-Making
  • Dissemination of Evidence-Based Interventions
  • Health Care Delivery and Quality of Care
  • Epidemiology
  • Measurement

View a selection of the latest papers published in Cancer Control.

Journal Highlights

  • Impact Factor of 1.990
  • Published at SAGE since 2017
  • Article Processing Charge of $2200 USD
  • Focus on prevention, detection, diagnosis, treatment, and palliative care of cancer
  • Fast and double-blind peer review by dedicated Associate Editors and Editorial Board Members

Cancer Control is a JCR-ranked, peer-reviewed open access journal whose mission is to advance the prevention, detection, diagnosis, treatment, and palliative care of cancer by enabling researchers, doctors, policymakers, and other healthcare professionals to freely share research along the cancer control continuum. Please see the Aims and Scope tab for further information.

打开APP